Ischemic Stroke and Increased Homocysteine Level
Objective: The main aim of this study was to find the correlation between ischemic stroke and increased homocysteine levels.
Type of Study: It is a cross sectional type of study.
Place and Duration of study: This study was carried out in a duration of 15 months from February 2018 April 2019 in medical departments of Jinnah Hospital Lahore.
Materials and Methods: A total of 100 patients were included in this study. The patients included in this study were between the ages of 40 to 80 years. Both genders were selected randomly. CT brain plain was obtained in all these patients and diagnosis of ischemic infarction was made of the basis of presence of hypo dense area. Blood samples were taken from all the patients and sent for homocysteine levels and the value of 15 µmol/L was labeled as high.
Results: Out study included 100 patients with 40(40%) females and 60(60%) males. 52.34± 6.57 years was the mean age. 60% cases had increased homocysteine levels and frequency was much higher in female patients which was found to be affecting 24(63.15%) cases. The frequency was much higher in people with increased age ranging between 60 to 80 years where it was found to be 65.38%.
Conclusion: One of the most fatal complications caused by increased homocysteine levels is ischemic stroke and the incidence is much higher in people with increased age ranging between 60 to 80 years.
Kim AS, Johnston SC. Global variation in the relative burden of stroke and ischemic heart disease. Circulation. 2011;124:314–23.
Mukherjee D, Patil CG. Epidemiology and the global burden of stroke. World Neurosurg. 2011;76(6):85-90.
Han L, Wu Q, Wang C, et al. Homocysteine, ischemic stroke, and coronary heart disease in hypertensive patients: a population-based, prospective cohort study. Stroke. 2015;46(7):1777-86.
Fahimfar N, Khalili D, Mohebi R, Azizi F, Hadaegh F. Risk factors for ischemic stroke; results from 9 years of follow-up in a population based cohort of Iran. BMC Neurology. 2012;12:117-19.
Ashjazadeh N, Fathi M, Shariat A. Evaluation of homocysteine level as a risk factor among patients with ischemic stroke and its subtypes. Iran J Med Sci. 2013;38(3):233-39.
Sadiq M, Alam MT, Kanpurwala MA, Khan MS. Frequency of hyper-homocysteinaemia in ischemic stroke patients of Karachi. J Pak Med Assoc. 2014;64(9):1063-66.
Rahman A, Dasgupta R, Quraishi FA, Saha UK, Ali Z, Hossain S, et al. Association between plasma homocysteine level and ischemic stroke. J Bangladesh Coll Phys Surg. 2013;31:128-33.
Iso H, Moriyama Y, Sato S, Kitamura A, Tanigawa T, Yamagishi K, et al. Serum total homocysteine concentrations and risk of stroke and its subtypes in Japanese.Circulation. 2004;109:2766–2772.
Parnetti L, Caso V, Santucci A, Corea F, Lanari A, Floridi A, et al. Mild hyperhomocysteinemia is a risk-factor in all etiological subtypes of stroke. Neurol Sci. 2004;25:13–17.
Tay SY, Ampil ER, Chen CP, Auchus AP. The relationship between homocysteine, cognition and stroke subtypes in acute stroke. J Neurol Sci.2006;250:58–61.
Hung CY, Wang KY, Wu TJ, Hsieh YC, Huang JL, Loh el-W, et al. Resistant hypertension, patient characteristics, and risk of stroke. PLoS One. 2014;9:e104362.
Hao L, Ma J, Zhu J, Stamp fer MJ, Tian Y, Willett WC, et al. High prevalence of hyperhomocysteinemia in Chinese adults is associated with low folate, vitamin B12 and vitamin B6 status. J Nutr. 2007;137:407-13.
Madonna P, de Stefano V, Coppola A. Hyperhomocysteinemia and other inherited prothromobotic conditions in young adults with a history of ischaemic stroke. Stroke. 2002;33:51-6.
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution 3.0 License.